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INTRODUCTION 
 Infections are an important factor to maternal and perinatal 
morbidity and mortality rates. The relative immunosuppression that occurs 
during pregnancy may alter the natural course of infectious diseases. 
Group B streptococci  is the commonest cause of  early onset neonatal 
infection  (5 – 10%) 
1. Although early reports in the 1930’s and 1940’s linked the 
GBS with postpartum infections and neonatal meningitis.  
GBS(Streptococcus agalactiae) has become recognized since 
the 1980’s as one of the most important causes of neonatal 
infection. 
2. 86 trials of empirical and  intrapartum antibiotics to women 
who transmitting infections , demonstrated a protective 
benefit against neonatal infection in the first week of life. 
(early onset disease) 
3. In  the 1990’s these efforts relate to the implementation of 
guidelines for intrapartum antibiotics prophylaxis at the risk 
of mothers endorsed and issued by the American college of 
Obstetricians & Gynaecologists (ACOG), the centres for 
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disease control and prevention (CDC)12, American academy 
of paedriatics(AAP). 
This practice shows in a significant decrease in the early onset 
disease. Based on these results updated guidelines were issued by the 
CDC12 in 2002 to recommend optimization of screening and treatment of  
pregnant women. 
2002 guidelines12 : 
The recommendations are 
- Antenatal women underwent  vaginal  - rectal screening for 
Group B streptococci colonization at 35-37 weeks. 
-  Antibiotic  prophylaxis in antenatal women  is needed for  
o Women with GBS disease positive infants. 
o Women in the  current pregnancy with positive bacteuria. 
o Women with unknown GBS – delivers  less than 37 weeks 
of gestation with  an intrapartum  fever or membrane  
rupture  for 18 hours . 
- Pencillin  is the drug of choice with ampicillin  as an alternative. 
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 2010 guidelines12 : 
- Detection of GBS by using a pigmented media and PCR 
assays 
-  Revised colony count threshold for laboratory’s to GBS in 
the bacteuria. 
-  Revised algorithms for  Group B streptococci screening 
and use of IAP for threatened preterm delivery,including 
one algorithm for preterm labour and one for  PROM. 
-  IAP agents are recommended to improve  the  antibiotic 
for penicillin-allergic women. 
- To Change in the penicillin dose . 
- To all newborns, neonatal management algorithm’s scope 
was applied.  
- It  recommends management that depend upon clinical 
appearance of the newborn and  risk factors ,adequacy of  
Intrapartum antibiotic Prophylaxis if  indicated . 
- Alterations  made to the algoritm to decrease unwanted 
evaluations in  relatively low risk neonates  for early onset 
Group B streptococci disease. 
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Group B streptococci was found in veterinary medicine as a reason 
for bovine mastitis. . Eickhoff and associates detected the role in neonatal 
infections. 
GBS as one of the most important cause for urinary tract infections, 
amnionitis, post partum endometritis, wound infection & intrapartum, post 
partum bacteremia also lead to premature rupture of membrane and 
preterm delivery. 
EPIDEMIOLOGY : 
 Asymptomatic vaginal colonization with GBS approximately 20% 
(range 4.6% - 40.6%). The risk of transmission from mother to fetus 42% - 
72% among neonates born to colonized mothers. 
 Maternal carriage – 20% (range 10%-30%) 
 Early onset maternal GBS sepsis – 1.5/1000 live births (0.15%) 
 Overall neonatal colonization 5% - 20% 
Risk factors for early onset neonatal infection with GBS1 
x Prematurity (<37 weeks gestation)  
x Clinical chorioamnionitis, intra-amnionitic infection, maternal fever 
(>100.4’C) 
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x Rupture of membranes >12 to 18hours 
x Previously delivered infant with invasive GBS disease. 
 GBS colonization showed variable prevalence during pregnancy6. In 
one study ,antenatal women  positive for GBS colonization  in 26 to 28 
week of gestation , 65 % remained colonized at term ,whereas 8 % with 
negative  Group B streptococci culture  were positive for Group B 
streptococci at term. During  birth 50 to 65 % of neonates have positive 
GBS colonization . Only 1 to 2 percent of neonates developed invasive 
GBS infection when compared to 98 % of neonates who remained healthy 
in positive GBS colonization. 
6In India, many studies shown low colonization and infection rates. 
GBS serotypes : 
           GBS are facultative , gram positive diplococcic also called 
streptococcus agalactiae belonging  to lancefield group B is composed of 
rhamnose – glucosamine polymer attached to peptidoglycan layer. The 
type specificity  by both capsular polysaccharide and protein antigens. 
Based on capsular polysaccharide ,there are 9 antigenically distinct 
serotypes.Types are Ia, Ib ,II to VIII. The protein antigen is designated by 
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single letter ‘c’ .GBS produces a variety of potential virulence 
determinants. These include 
x Beta hemolysin 
x C5a peptidase 
x Lipotechoic  acid  
x Cell surface protein  
x Hyaluronic acid lyase  
x Cell surface penicillin binding protein. 
6One study in USA  shown that  serotypes Ia ,III and V  for 76 – 86 
percent of early onset  disease in neonates and  women.  
 Serotype III , I a & V is accounted for late onset disease. The most 
common serotypes in india are serotype III , II and Ib.  Important  virulent 
factor is the polysaccharide capsule. 
Pathogenesis : 
Early onset disease : 
¾ The most important risk factor is the presence of the Group B 
streptococci in the genitourinary tract at deliveries.  
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¾ The organism reach the amniotic fluid from maternal genitourinary 
tract when rupture of membarane occurs 
¾ Whereas newborn contact occurs during the passage in maternal 
genitourinary tract . 
¾ When aspiration of amniotic fluid contaminated with GBS 
colonization occurs it results in lower respiratory tract infection and 
pulmonary epithelial cell damage leads to pneumonia and 
respiratory distress . 
¾  If infection occurs in intact amniotic membrane it results in still 
birth or death within few hours of birth. 
Late onset disease: 
 Horizontal transmission plays a major role. 
x Close contact with mother 
x Hospital Acquired infection 
x Breastfeeding. 
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Clinical features: 
Neonatal morbidity: 
x Early onset disease 
x late onset disease 
Early onset disease 
x within the first 7 days of life. 
x The initial manifestation is respiratory distress .  
x Pneumonia and septicemia are the most common 
manifestations.  
x Its more common in preterm babies. 
Late onset disease occur after 
x 7 days and upto 3 month of age. 
x  Meningitis ,Sepsis and Osteoarthritis.  
x The signs and symptoms are fever, lethargy, irritability, 
poor intake of  feeding and tachypnoea. 
x  Respiratory distress is less common.  
x About 20 percent GBS meningitis have permanent 
neurological problem. 
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They are  
x sensorineural hearing loss 
x mental retardation  
x cortical blindness  
x seizures. 
6Neonatal 
manifestation Early onset Late onset 
Onset First week of life One week to 3 month 
of age 
Manifestation Respiratory distress, 
pneumonia , sepsis 
Sepsis , meningitis , 
osteoarthritis 
premature Increased  No change 
Obstetrical 
Complications  
Frequent 70% Uncommon  
Mode of transmission Vertical   horizontal 
Predominant serotypes  Ia ,III , VII III ,Ia ,V 
Mortality percentage 10 – 15 % 2- 6 % 
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Maternal morbidity : 
x  Chorioamnionitis    
x  Endometritis , 
x Urinary Tract infections , 
x Pyelonephritis and 
x  GBS bacteraemia 7can occur.  
x  Prolonged labour  
x  Premature rupture of membrane9  
x  Preterm  delivery 9 
x Fever in post partum patients  
x Less commonly associated with  wound infection , 
x  Pelvic abscess  
x Septic pelvic thrombophlebitis10  and 
x  Osteomyelitis. 
11 
 
12Detection of GBS colonization: 
x The time for antenatal cultures  from 35 to 
37 weeks of gestation. 
x GBS colonize in the genitourinary and 
gastrointestinal tracts 
x Sampling time,  Body area sampling, 
media for bacteriological culture are the 
important factors to detect GBS 
colonization accurately.  
x The lower vagina and anorectal sites yields 
highest colonization rate when sampled. 
x  Selective broth medium is Todd – Hewitt 
broth with gentamycin (8microgram/ml) 
that decreases  the gram negative enteric 
bacilli growth and other normal flora  and 
results in increased culture sensitivity for 
GBS to over 90 percent. 
  In 1996 , the centre for disease control and prevention guidelines 
recommends two methods of GBS disease prevention. 
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1. Risk - based  approach 12: 
Antibiotics are given on the presence of  risk factors in antenatal or 
intrapartum period.  
Risk factors are as follows 
x Preterm labour or  
x Premature rupture of membrane (greater than 18 
hours)or 
x  Intrapartum  fever >100.4 f  or  
x  Previous newborn  had GBS disease and  
x GBS bacteuria during pregnancy. 
2.Universal swab based screening12 : 
x Routine vaginal / rectal swab for GBS sceening in women at 
35 – 37 weeks of gestation. 
x Give intrapartum antibiotics 
(a) If the vaginal / rectal swab or urine cultures show the 
presence of GBS or  
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(b) If the women has given birth to an infant with invasive GBS 
disease or  
(c) If the GBS culture report is unknown , and a risk factor is 
present . 
In 2002 , a further study on the above two methodologies indicated 
that regular screening for the infection would decreases 50 %  newborn 
infections. 
The CDC revised guidelines August 2002 recommends screening 
are pregnant women at 35 – 37 week of gestation , with the lower vaginal 
and rectal swab for GBS culture. Swabbing  the lowervagina and anorectal 
sites increases the yield for GBS when compared with swabing the vagina 
or swabing the cervix alone . 
The latest uptate of 2010 is based on the standardizes the lab 
methods, changes the dose of antimicrobial prophylaxis and upd ates the 
recommendations for premature infants and neonates at risk of early 
infection. 
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Methods: 
             Centre for Disease Control (CDC) Guidelines12: 
Samples are taken by swabbing the skin from vaginal introitus to the 
anus without using the speculum. Materials are transported using Amies 
medium.The transported medium are then transferred to suitable selective 
broth medium like Todd Hewitt broth supplemented with either 
gentamycin 8 microgram/ml or nalidixic acid 15 microgram / ml . The 
inoculated selective broth is incubated for 18 – 24 hours at 35 – 37 C in 
ambient air or with 5 % Co2.Subculturing can be done using sheep blood 
agar plate. GBS was identified using CAMP ( Christie, Atkins& munch-
petersen) test. . 
12Indications for Intrapartum antibiotic prophylaxis: 
x Previous newborn with invasive GBS disease. 
x GBS bacteriuria during present pregnancy. 
x Positive GBS screening laboratory test during present 
pregnancy. 
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x Unknown GBS status,because culture not attempted and or 
results unknown or delivery at less than 37 weeks gestation, 
PROM >18hours, Intrapartum >100 4 F. 
Intrapartum Prophylaxis not indicated 
x  GBS screening culture positive in previous pregnancy 
x Planned Caesarean delivery 
x Negative GBS culture 
Recommended Regimens 
Drug  of choice :  
Penicillin G 5 million units as intravenously, followed by 2.5           
million unit as intravenously every 4 hours until delivery. 
Alternative:    
Ampicillin 2 g intravenously followed by 1g intravenously every 4 
hours until delivery. 
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If penicillin Allergic patient not at  high risk for anaphylaxis :  
Cefazolin 2g iv then 1g iv every 8 hours until delivery. 
If penicillin Allergic patient at high risk for Anaphylaxis : 
x Clindamycin 900mg intravenously every 8 hours until delivery  
x or Erythromycin 500mg intravenously every 6 hours until delivery. 
GBS resistant to Clindamycin or Erythromycin or Susceptibility 
unknown: Vancomycin 1g intravenously every 12 hours until delivery. 
Clinical challenges 
Group B streptococci bacteruria during pregnancy 
x The presence of bacteruria  in pregnant women is a marker for 
heavy genital tract infection.  
x  Group B bacteruria during pregnancy should receive intrapartum 
           prophylaxis.  
x Lower Vaginal and anorectal screening at 37- 38 weeks is not 
           necessary . 
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x Women with such bacteruria or urinary tract infections with group B 
streptococci should receive treatment as well as intrapartum 
prophylaxis. 
Planned caesarean delivery 
Because group B infection can cross the intact amniotic membranes, 
a caesarean delivery does not prevent mother to child transmission of the 
infection. 
Threatened preterm delivery 
Preterm delivery  is a risk factor for group B streptococcal infection. 
Timing of delivery  not known,  because assess the delivery time is 
difficult in preterm labour, so intrapartum antibiotic prophylaxis is given in 
threatened preterm delivery is challenging. 
Threatened Preterm Delivery 12 
Onset of labor or rupture of membranes at <37 weeks gestation with 
significant risk for imminent preterm delivery 
¾ If No GBS Culture- Obtain GBS culture and start intravenous 
penicillin, if no growth in 48 hours, stop penicillin. If GBS positive, 
continue penicillin for 48 hours. 
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¾ If GBS +VE- GBS Prophylaxis 
¾ If GBS-VE- No GBS Prophylaxis 
Side Effects and Consequences of Chemoprophylaxis 
          Allergic reactions 
          Anaphylactic reactions 
         GBS strain resistant to standard therapy. 
          Increasing emergence of bacterial resistance to antimicrobial agents 
in hospital and community settings, assessment of the impact and 
continued effectiveness of interventions based on antimicrobial 
prophylaxis is critical. 
Rapid test for GBS1: 
x Fluorescence in situ Hybridization 
x Latex Agglutination test 
x Optical immunoassays and enzyme immunoassays 
x DNA probes 
x Nucleic acid amplication test 
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If appropriate techniques for rapid detection of GBS become 
commercially available, they may be integrated into the currently 
recommended screening strategy. 
Vaccines15: 
Type specific antibody deficiency in maternal serum are related to 
disseminated GBS infection in young infants thus immunization of women 
with GBS type specific polysaccharides results in prevention of infant 
disease by placental transport of protective antibodies. 
Native type Ia, II, III polysaccharides are nontoxic, safe and 
immunogenic. Vaccine induced type specific antibodies given a lethal 
challenge of homologous organisms.  Many clinical trials and research are 
taking place to develop a safe vaccine.15 The challenges faced with 
vaccination implementation are, 
1. Large and appropriate sample size is necessary to demonstrate 
vaccine efficacy. 
2. Duration of protection offered by the vaccine is currently 
unknown. 
3. Shifts in the GBS serotypes responsible for infection over time10 
           Hence until a safe, effective, and economical vaccine achieves 
licensure, it is very much important to continue current recommendations 
of screening and treatment. 
20 
 
REVIEW OF LITERATURE 
  In  ancient Indian texts 1500B.C  puerperal sepsis have recorded. 
good hygiene leads to a reduction in the perinatal disease16. 
 In 1879  Louis Pasteur described  Streptococcus as a causative 
organism for puerperal sepsis17. 
 In the early 1930s, Rebecca Lancefield reported her grouping 
system for hemolytic streptococci. Group A Streptococci (pyogen) was 
widely described as the major pathogen associated with puerperal sepsis18. 
GBS initially thought as commensal till 1937 when Fry found 
several cases of puerperal fever19. 
During the 1970 and 1980s GBS caused neonatal and maternal 
mortality(15 – 50 %) and morbidity and emerged as an significant 
pathogen20. 
In the 1980s trials have shown that administering antibiotics to 
women in labour have demonstrated the reduced risk of transmission of 
GBS infection in neonates. Thus prevents invasive disease in neonates21. 
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 Between 1984 and 1989 a prospective study of colonization with 
GBS in pregnancy among 2877(parturients), Regen JA, Klebanoff MA, 
Nugent RP found an  significant relationship between preterm labour and 
low birth weight  to high colonization of GBS. Neonatal sepsis occurred in 
2.6/1000 live births in women with GBS colonization  and  0.4/1000 live 
births without  GBS colonization11.   
 Between 1996 and 2009 feb – A systematic review by Valkenburg-
Vanden Berg AW, HOutman-Roelofsen RL advise to take GBS culture at 
35-37 weeks of gestation, if positive for GBS colonization, then give 
intrapartum prophylaxis not only  to GBS positive patients , give to all 
preterm deliveries. Eventhough 6 % of GBS carriers remains undetected 
antenatally ,review confirms recommendations to screen pregnant women 
for colonization  of GBS at 35 – 37 weeks gestation.  
 June 1998-April 1999 -  AA  Kulkarni,  SG  Pawar,  CA  
Dharmadikari, RD Kulkarni  conducted trial to find out the prevalence of 
GBS in pregnant women and their neonates. From june 1998 – april 1999  
a total of  317 pregnant women was examined for GBS. They concluded 
that Selective broth medium was found to be a superior  transport  medium 
over Stuart transport medium and filter paper method. All isolates are 
sensitive to Ampicillin, Erythromycin, Pencillin followed by 
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Chloramphenicol 66.6%. All the strains were resistant to Gentamicin 
followed by Tertracycline 94.4% and Kanamicin 88.8% 
 Between 1999-2001 and 2003-2005 – Simetka O, Petros M, 
Poclesvova H viewed 8484 consecutive term pregnancies of women 
between 1999-2001 before the introduction of guidelines and 2003-
2005following the guidelines. In 1999-2001 there were 3.35/1000 neonates 
with EOGBS infection in which 1.96/1000 had invasive disease. In group 
2003-2005 there were 2.86/1000 neonates with EOGBS infection in which 
1.22/1000 had invasive disease. There was 15% decrease of EOGB disease 
following the introduction of guidelines. 
 Between September 2002 and march 2004 – Dechen TC, Sumit K, 
Ranabir P observational cross section al study of genital colonization of 
GBS was conducted on 524 pregnant women in their third trimester. Three 
high vaginal swabs was obtained from all the pregnant women admitted at 
term and preterm labour. Two swabs were used for aerobic culture and 
third for Gram staining. The culture positivity rate of GBS was 4.77%. the 
culture positivity in <36 weeks of gestational age was 6.93%. this relation 
was statistically significant. 28% developed PROM. 64% of culture 
positives had preterm labour.  
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In  2003 orrett FA – the  prospective study of colonization with 
group B streptococci in 201 pregnant women.the prevalence of GBS 
colonization was 32.9%.GBS more frequently from women >24 yr 
(36.6%) than those younger than 24 yr (26.9%) colonization rates were 
significantly greater among multigravid women than primigravid women. 
The carriage rate of GBS in Trinidad remain high. 
Vaginal and rectal cultures are obtained from 1197 pregnant women 
with gestational age more than 24 weeks by Namavar Jahromi B,Poorarian 
S ,Poorbarfehee S. Out of the 1197 pregnant women, 110 (9.1%) have 
been positive for Gbs colonization..out of the 110 women (group 1) 36.3% 
developed preterm labour as compared with 14.3% in group 2.16.3% in 
group 1 develops  PROM compared with 0.5% in group 2. In this study  
shows the prevalence of group b streptococci in antenatal women is 9.1% 
           Between 2003 and 2006 june – a retrospective case control study of 
prevalence of  GBS colonization in pregnant women. The  total of 118 
pregnant women was enrolled for study,59 women in 35th _ 37th week of 
gestation free from risk factors for infection (control group) and 59 women 
in 25th – 41th week  week of gestation with risk factors for infection.GBS 
colonization was recorded in 24.6% women ,20.3% control and 28.8% 
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women at risk of infection,yielding a statistically non significant 
difference. 
Between nov 2004 to feb 2005 – the prevalence of GBS 
colonization in pregnant women at thummasat hospital  Thailand by 
Siripen Tor Udom,Pharcchat Tor Udom ,Wanwarang Hiriote was carried 
out from Nov 2004 to Feb 2005,406 pregnant women are examined for 
GBS.GBS colonization rate was 16% in pregnant women. All the positive 
GBS isolates were sensitive to Ampicillin , Penicillin, Vancomycin and 
Cephazolin. Resistant was seen with Clindamycin (3%) and Erythromycin 
(1.5%). 
Mcdonald H,Vigneswaran R, O’Loughlin JA conducted a 
prospective study vaginal swabs are collected  from 692 women at  24 
weeks  of   gestation  and   cultured  for  GBS.   The  incidence  of  group  B  
streptococci in antenatal women is 13.2%. its strongly associated with 
preterm labour and preterm rupture of membranes23. 
Nomura ML,  passini junior R, Oliveira UM , Calil R, two vaginal 
and two anal swabs were taken from pregnant women with risk factor  of 
preterm labour or premature rupture of membranes. Prevalance  of 
maternal GBS colonization was 27.6%.30% for premature rupture of 
membranes ,25.2% for preterm labour and 17.8% for preterm labour and 
25 
 
premature rupture of membranes . The neonatal  colonization rate was 
3.1%.  
Krasnianin E , Skret – Magierlo J ,Witalis J ,Barnas E , kluz T 
,koziel A ,skret A done a study and related  the incidence of GBS 
colonization in pregnant women and the transmission to the newborn. 
Total of 100 consecutive parturient women and their newborn are taken 
into study. GBS colonization positive  in 19 women and in 4 newborns . 
Two vaginal and caesarian delivery in that four colonized newborns. 
In 2009 – A systemic review by valkenburg – van den berg AW, 
sprij  AJ ,Dekker FW  for association between colonization with GBS and 
preterm delivery. Totally they reviewed sixteen follow up studies and four 
case control studies and conclude that there is no association between GBS 
colonization and preterm delivery whereas they related the increased risk 
of subsequent maternal GBS colonization in preterm delivery. 
In 2012 – a retrospective cohort study of group b streptococcus 
colonization in repeated pregnancies of  158 women with two or more 
deliveries ,Page – Ramsey SM, Johnstone SK , Kim B found colonization 
rate in subsequent pregnancies for initially GBS – colonized women was 
42% compared with 19% for women who were not colonized with GBS in 
the index pregnancy. 
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In a study involving 326 antenatal women, Chau.S, Arul kumaran .S 
observed the group B streptococci colonization in 14.1% of pregnant 
women. All the patients were screened after 32 weeks of gestation. 
They further concluded that, antenatal screening for GBS carrier 
status prior to 32 weeks of gestation might not identify women at high risk 
of preterm labour or premature rupture of membranes.20 
Badri MS et al did a cross sectional study to detect the rate of 
maternal colonization and found to be 20.5%.36 
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AIM OF THE STUDY 
x To study the prevalence of group B streptococcal infection at 
35-37 weeks of gestation in normal asymptomatic primi 
gravida, attending antenatal clinic. 
x To study the incidence of preterm labour, premature rupture 
of membrane, and prolonged labour in GBS Positive and in 
GBS negative women. 
x To study the mode of termination of pregnancy in GBS 
positive and in GBS negative  women. 
x To study the fetal outcome such as Apgar score, Birth weight, 
NICU admission in GBS positive and in GBS negative 
women. 
x To study the maternal morbidity in GBS positive and in GBS 
negative women. 
 
 
 
28 
 
SUBJECTS AND METHODS 
All primi gravida women of 35-37 weeks of gestation attending the 
antenatal clinic of R.S.R.M Lying in Hospital, Stanley Medical college, 
Royapuram, Chennai were recruited for the study, based on the inclusion 
and exclusion criteria. 
Inclusion criteria: 
x All Primi gravida 35-37 weeks of gestation 
x Cephalic Presentation 
x No history of intake of antibiotics during the past two weeks 
x No preexisting medical disorders. 
Exclusion criteria: 
x Primi gravida less than 35 weeks of gestation 
x Non Cephalic presentation 
x High risk pregnancies 
x Multiple pregnancy 
x Multigravida 
x History of intake of antibiotics during the past two weeks 
x Preexisting medical or surgical disorders. 
The study was approved by the Ethical Committee 
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METHODS 
STUDY: CROSS- SECTIONAL 
DURATION OF STUDY: JUNE 2012TO DECEMBER 2012 
SAMPLE SIZE: 250 Women based on inclusion and exclusion criteria 
HISTORY AND EXAMINATION: 
x A detailed obstetric history was taken, ie; last menstrual 
period and expected date of delivery,  
x Menstrual history,  
x Marital history,  
x Obstetric history,  
x Past history for medical or surgical disorders , 
x  Investigation ie; Height, Weight, BMI,  
x BP, Pulse rate,  
x Hb%,  
x Urine albumin, sugar, deposits,  
x Blood sugar,  
x Blood grouping and typing,  
x HIV,  
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x VDRL,  
x HbsAg,  
x Examination ie, Cardiovascular system, Respiratory system,  
x Obstetric examination and  
x USG examination for gestational age. 
SWAB COLLECTION 
x Samples are taken by swabbing the skin from vaginal introitus to the 
anus without using the speculum. 
x  Materials are transported using Amies medium. 
x The transported medium are then transferred to suitable selective 
broth medium like Todd Hewitt broth supplemented with either 
gentamycin 8 microgram/ml or nalidixic acid 15 microgram / ml . 
The inoculated selective broth is incubated for 18 – 24 hours at 35 – 
37 C in ambient air or with 5 % Co2.  
x Subculturing can be done using sheep blood agar plate. 
GBS was identified using CAMP ( Christie, Atkins& munch-
petersen) test. Composition of culture media 
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Amies transport media 
Charcoal, sodium chloride, phosphate buffer, potassium chloride, 
sodium thioglycollate, calcium chloride, magnesium chloride, agar. 
Todd-Hewitt broth: 
Meat infusion, tryptone, glucose, sodium bicarbonate, sodium 
chloride, di sodium phosphate. 
FOLLOW UP 
GBS Positive or Negative, Patients are followed up for the rest of 
the antenatal period. 
PARAMETERS 
x Preterm labour less than 37 weeks of gestation. 
x Premature rupture of membranes greater than 18 hours. 
x Mode of onset of delivery whether spontaneous labour , 
induction labour or lower segment caesarian section.  
x Prolonged labor. 
x Mode of termination of pregnancy. 
x Maternal morbidity such as fever. 
x Fetal outcome such as Birth weight, Apgar score, NICU 
admissions. 
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Preterm labour - onset of labour prior to 37 completed weeks of gestation 
was taken as positive criteria for preterm labour. 
Premature rupture of membranes – the rupture of membranes prior to 
the onset of labour is taken as the criteria. 
All the deliveries were monitored with partogram. 
Mode of Onset of Labor whether Spontaneous or Induced were 
recorded. 
Mode of Delivery 
The patients were followed up and the type of delivery noted. 
Prolonged Labour: 
Labour was considered prolonged when it grossly exceeded the 
average duration of labour for the first and second stage, based on the 
partograph (6hrs for first stage and two hrs for second stage). 
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Statistical Methodology: 
All the parameters were studied for all the 250 women and the data 
was analyzed using chi square test.  The significant parameters were 
further studied using  odds ratio and the confidence limits were arrived. A 
p value of <0.05 is statistically significant. 
The total number of subjects were screened were 250 out of  which 
9 patients were found to be positive for Group B streptococcus and 241 
were found to be negative for the culture.               
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TABLE-1 : Group B Streptococcus 
 
Frequency Percent 
Valid 
Percent 
Cumulative Percent 
Valid (+ve) 9 3.6 3.6 
 
3.6 
(-ve) 241 96.4 96.4 
 
100.0 
Total 250 100.0 100.0 
 
 
 
 
The prevalence of Group B streptococcus in Primi gravida is 3.6% 
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TABLE-2 : SOCIOECONOMIC STATUS * GROUP B 
STREPTOCOCCUS 
  
GBS 
Total 
(-ve) (+ve) 
SES MIDDLE ECONOMIC 
STATUS 
 87 
 
2 89 
 (36.1%) (22.2%) (35.6%) 
LOWER ECONOMIC 
STATUS 
 154       7 161 
 (63.9%) (77.8%) (64.4%) 
Total  241 9 250 
 100.0% 100.0% 100.0% 
 
Chi-Square Tests 
 
Value df P value 
Pearson Chi-
Square 
.729a 1 .393 
Continuity 
Correctionb 
.249 1 .618 
 
Risk Estimate 
  
Value 
95% Confidence Interval 
Lower Upper 
Odds 
Ratio for 
GBS ((-
ve) / 
(+ve)) 
.506 .103 2.488 
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Our hospital essentially caters from the low socioeconomic status. P value 
is 0.393, 0.618 its statistically insignificant , the colonization does not 
seem to affect any particular socio economic group.  
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TABLE-3 Mode of onset of labour * GBS 
  
GBS 
Total (-ve) (+ve) 
Mode 
of  
onset 
of 
labour 
Spontaneous  196 5 201 
 (81.3%) (55.6%) (80.4%) 
LSCS  3 1 4 
 (1.2%) (11.1%) (1.6%) 
Induction  42 3 45 
 (17.4%) (33.3%) (18.0%) 
Total  241 9 250 
 100.0% 100.0% 100.0% 
 
Chi-Square Tests 
  Value df P value 
Pearson Chi-
Square 
7.215a 2 .027 
 
The mode of onset of labour in both group B streptococcal positive and 
negative women was compared. 
x 5  patients (55.6%) in the positive group and 196 (81.3%) in the 
negative group went in for spontaneous labour 
x 1 (11.1%) patients in the positive group and 3(1.2%) in the negative 
group underwent elective LSCS for non obstetric indications. 
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x 3 (33.3%) in the positive group and 42 (17.4%) in the negative 
group were induced electively.  
 
The percentage of patients who went in for spontaneous labour was 
slightly more in the positive group than in the negative group. However 
this association was statistically insignificant. 
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TABLE 4 GBS * Prolonged labour 
 
Prolonged   Labour 
Total No yes 
GBS (+ve)  4 5 9 
 (44.4%) (55.6%) (100.0%) 
(-ve)  233 8 241 
 (96.7%) (3.3%) (100.0%) 
Total  237 13 250 
 (94.8%) (5.2%) (100.0%) 
 
Chi-Square Tests 
 
Value df P value 
Pearson Chi-Square 48.023a 1 .000 
Continuity Correctionb 38.011 1 .000 
 
Risk Estimate 
 
Value 
95% Confidence Interval 
Lower Upper 
Odds Ratio for 
GBS ((-ve) / (+ve)) 
36.406 8.191 161.821 
 
 
40 
 
The percentage of patients who went in for prolonged labour was 55.6% 
(5) in the positive group and 3.3%( 8 ) in the negative group. 
 
The association of increased duration of labour with group B 
streptococcal colonization was found to be statistically significant with p 
value of 0.00  
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TABLE 5 GBS * Preterm Labour 
 
Preterm Labour 
Total NO Yes 
GBS (+ve)   6 3 9 
 (2.6%) (16.7%) (3.6%) 
(-ve)  226 15 241 
 (93.8%) (6.2%) (100.0%) 
Total  232 18 250 
 (92.8%) (7.2%) (100.0%) 
 
Chi-Square Tests 
 
Value df P value 
Pearson Chi-Square 9.543a 1 .002 
Continuity Correctionb 5.917 1 .015 
 
Risk Estimate 
 
Value 
95% Confidence Interval 
Lower Upper 
Odds Ratio for 
GBS ((-ve) / (+ve)) 7.533 1.713 33.132 
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It was observed that 3(16.7%) patients who were colonized with the 
GBS went in for preterm labour whereas 15 (6.2%) patients who were not 
colonized with GBS developed preterm labour. 
 
The association between preterm labour and GBS positive women 
was found to be statistically significant – p value of 0.002  
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TABLE 6 GBS * PROM 
 
PROM 
Total No YES 
GBS (+ve)  7 2 9 
 2.9% 25.0% 3.6% 
(-ve)  235 6 241 
 97.5% 2.5% 100.0% 
Total  242 8 250 
 96.8% 3.2% 100.0% 
 
Chi-Square Tests 
  Value df P value 
Pearson Chi-Square 10.906a 1 .001 
Continuity Correctionb 5.466 1 .019 
 
Risk Estimate 
  
Value 
95% Confidence Interval 
Lower Upper 
Odds Ratio for GBS  
((-ve) / (+ve)) 
11.190 1.910 65.571 
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The number of patients who developed premature rupture of 
membranes, was found to be 2(25.0%) and 6(2.5%) in group B 
streptococcal positive and negative women respectively. 
 
The association of premature rupture of membranes with 
streptococcus colonization was found to be statistically significant, 
Pvalue0.001 
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TABLE 7 GBS * Mode of Delivery 
 
Mode of Delivery 
Total INSTRUMENTAL LSCS Vaginal 
GBS (+ve)  1 5 3 9 
 11.1% 55.6% 33.3% 100.0% 
(-ve)  6 41 194 
 
241 
 2.5% 17.0% 80.5% 100.0% 
Total  7 46 197 
 
250 
 2.8% 18.4% 78.8% 100.0% 
 
Chi-Square Tests 
  Value df P value 
Pearson Chi-Square 11.757a 2 .003 
 
 
 
 
 
46 
 
 
The mode of delivery in all patients was followed up. The incidence 
of LSCS in GBS positive patients was found to be 55.6% and that in the 
GBS negative group was found to be 17%. 
 
It was found that LSCS delivery is more common in group B 
streptococcal positive patients than in negative patients with p value of 
0.003 
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TABLE 8 APGAR SCORE 
1 MINUTE >7 5-7 <5 
GBS+ve 4 ( 1.8%) 2(16.7%) 3(27.3%) 
GBS-ve 223(92.5%) 10(4.1%) 8(3.3%) 
 
5 MINUTE >7 5-7 <5 
GBS+ve 6(2.6%) 2(15.4%) 1(33.3%) 
GBS-ve 228(94.6%) 11(4.6%) 2(0.8%) 
 
The APGAR score of all the babies born to the study group was 
observed and it was found that the babies born to Group B streptococcal 
colonized mothers were having low APGAR score than when compared 
with that of the positive group. 
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 The association of such low APGAR scores was found to be 
statistically significant, P value of 0.000 for one minute Apgar, P value of 
0.001 for five minute Apgar. 
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TABLE 9 : BIRTH WEIGHT 
 <2kg 2-2.5kg 2.6-3kg >3kg 
GBS+ve 2 (66.7%) 5 ( 7.2%) 2 (1.4%) - 
GBS-ve 1 ( 33.3%) 64 (92.8%) 137 (98.6%) 39(100%) 
 
Chi-Square Tests 
  Value df P value 
Pearson Chi-Square 40.354a 3 .000 
 
The birth weight of the newborns born to the study group was 
divided in to <2kg, 2-2.5kg, 2.6-3kg, >3kg categories. 
It was found that  66.7% of the babies born to the mothers in the 
positive group were having birth weight  less than 2 kg, where as 98.6% of 
the newborns in the negative group were having birth weights in the range 
of 2.6 -3 kg. 
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The association between Low Birth Weight and GBS Positive women 
statistically significant, P value  0.000 
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TABLE 10 GBS * NICU Admission 
 
 
NICU Admission 
Total NO YES 
GBS (+ve)  5 4 9 
 2.1% 30.8% 3.6% 
(-ve)  232 9 241 
 96.3% 3.7% 100.0% 
Total  237 13 250 
 94.8% 5.2% 100.0% 
 
Chi-Square Tests 
 
Value df P value 
Pearson Chi-Square 29.168a 1 .000 
Continuity Correctionb 21.494 1 .000 
 
Risk Estimate 
  Value 
95% Confidence Interval 
Lower Upper 
Odds Ratio for 
GBS ((-ve) / 
(+ve)) 
20.622 4.724 90.031 
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The number of babies admitted in the Neonatal intensive care unit in 
the group B  streptococcal positive group were 4(30.8%) and in negative 
group were 9(3.7%). 
 
There was significant association between, positive patients and the 
need for neonatal admission, P value 0.000 
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TABLE 11 GBS * Indication for Neonatal Admission 
 Indication for Neonatal Admission Total 
Anomaly Fetal 
Distress 
Hypo 
Thyroid 
LBW Mother 
Diabetic 
No Weak 
Cry 
GBS 
(+ve) 
0 
0% 
1 
25.0% 
0 
0% 
3 
60.0% 
0 
0% 
6 
2.1% 
0 
0% 
 9 
3.6% 
(-ve) 1 
.4% 
3 
1.2% 
1 
.4% 
2 
.8% 
1 
.4% 
222 
92.1% 
1 
.4% 
241 
100.0% 
Total  1 
.4% 
3 
1.2% 
1 
.4% 
5 
2.0% 
1 
.4% 
228 
91.2% 
1 
.4% 
 250 
100.0% 
 
The number of babies admitted in the intensive care unit in the 
group B streptococcal positive women were 4 ,3 due to LBW (60.0%) and 
1 due to  fetal distress (25%)  and in negative group were 9, 2 due to LBW 
(0.8%),  3 due to fetal distress (1.2%), 4 due to other causes. 
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There was significant association between, positive patients and the 
need for neonatal admission, P value of 0.052 
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TABLE 12 : NEONATAL  SEPSIS AND MORTALITY 
 YES NO 
GBS+ve 1 (0.4%) 8 (3.2%) 
GBS-ve 2 (0.8%) 239(95.6%) 
 
Out of the 9 babies in the positive group one baby died of sepsis ( 0.4%) 
due to streptococcal bacteremia and there were two deaths in the negative 
group one due to anomaly, other one due to meconium aspiration 
syndrome.  
 
There was no statistical significance between the GBS status of 
mother and neonatal  mortality when compared among the two groups. 
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TABLE 13 : MATERNAL MORBIDITY  
 
Maternal  
Morbidity 
Total NO YES 
 GBS +VE  7 2 9 
 2.8% 66.7% 3.6% 
GBS -VE  240 1 241 
 97.2% 33.3% 96.4% 
                            
TOTAL 
 247 3 250 
 98.8% 1.2% 100.0% 
 
Chi-Square Tests 
 Value 
Pearson Chi-Square 0.000 
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The maternal morbidity was measured in terms of fever, wound 
infection, chorioamnionitis, etc., In this study , in GBS positive group one 
had fever, another one had wound infection, in GBS negative group one 
had fever.  
 
There is statistically significant association between GBS 
POSITIVE women and Maternal morbidity, P value of 0.000 
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DISCUSSION 
This study about GBS infection on the various aspects of pregnancy, 
labour, fetal outcome was conducted at R.S.R.M Lying in hospital, Stanley 
medical college between   JUNE 2012  AND  DECEMBER 2012   in 250 
asymptomatic primi gravida  attending the antenatal clinic. 
           The Prevalence of GBS colonization (TABLE 1) among the 
pregnant women was analyzed it was found that the vaginal colonization 
with GBS differ worldwide approximately 20% 
           Kulkarani AA, Pawar SG, Dharmadhikari CA, Kulkarni RD 3found 
that the vaginal colonization with GBS in pregnant women is 2.52% 
           Vijayan sharmila,Noyal Mariya Joseph, Thirunavukarasu Aran 
babu, Latha Chaturvedule, Sujatha Sistla2 found that the Genital tract GBS 
colonization in pregnant women is 2.3% 
 NamavarJahromi B, Poorarian S, Poorbarfeehees found that he 
prevalence of GBS colonization in pregnant women is 9.1% 
 Tim  SF,  Lyon  DT,  Chung  KH30 found that GBS Prevalence is 
7.40% 
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 Lucto M et al29 found that GBS Prevalence is 12%                                
Chaus, Arul kumaran et al24 found that GBS Prevalence is 14.10% 
 Mc Donald, Vigneshwaran R, O’ Loughlin23 found that GBS 
Prevalence is 13.20% 
 Manuel et al28 found that GBS Prevalence is 14.60% 
 Liang ST, Lau SP, Fok TF25 found that GBS colonization in 
pregnant women is 19% 
 Regan JA, Klebanoff et al22 found that GBS Prevalence is 21% 
 Dalal S Lahiri47 found that GBS Prevalence rate is 10% 
 Towers Creig V, Lewis David46 found that GBS Prevalence  
rate is 13% 
 Garland SM, Kelly N40 found that GBS Prevalence rate is 12.90% 
 Mani V, Jadhav49 found that GBS Prevalence rate is 14% 
 Choudary et al 48 found that GBS Colonization rate  is 16% 
 Badri MS et al41 found that GBS colonization rate is 20.50% 
 Zalenik DF et al31 found that GBS prevalence rate is 14% 
 Mariijane, Krohn et al34 found that GBS Prevalence rate is 21.60% 
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 Campdel et al38 found that the GBS prevalence rate is 22% 
 Mc  Duffe  RS  Jr,  Mc  Nabbs32 found that the GBS prevalence  
rate is 18% 
 Present study was found that the GBS colonization in pregnant 
women is 3.6% 
 The prevalence of GBS towards the age group <20 year, 21-25 
year, >25 year were analyzed. It was found that there was no correlation 
between the presence of GBS infection and the age group. 
           Gerards CJ, Lab BP, Hoog 37 found no correlation between age and 
GBS colonization. 
 Hastings MJ, Easmons CS, Neill J 44 found that no correlation 
between age, blood group and GBS Colonization. 
In TABLE 2, the  prevalence  of  GBS  in  a  Lower  and  Middle  
socioeconomic group was analyzed, there was no significant correlation 
between Lower and Middle socio economic group and GBS Colonization. 
In TABLE 3, Mode of onset of labour among the study group were 
analyzed. 
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Gerards CJ, Lab BP37 studied the effect of streptococcus carrier state 
on the mode of onset of labour in patients with GBS colonization went in 
for spontaneous labour, there was no statistical correlation between the 
mode of onset of labour and GBS Positive women. 
 The same was observed in our study where 5 ( 55.6%) GBS positive 
women went in for spontaneous labour and 196 ( 81.3%) GBS negative 
women went in for spontaneous labour. There was no statistically 
significant correlation, between GBS positive women and mode of onset of 
labour. 
In TABLE 4, The incidence of prolonged labour in GBS positive 
and GBS negative women were analyzed. 
 Hastings MJ, Easmon CS, Neill J44 found that the incidence of 
prolonged labour in GBS positive women is 20% 
 Mc Duffee RS Jr, Mc Nabbs32 found that the incidence of prolonged 
labour in GBS positive women  is 33% 
 Present study shows that the percentage of patients who went in for 
prolonged labour was 55.6% ( 5 ) in the positive group and 3.3% ( 8 ) in 
the negative group. 
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 There was statistically significant association between GBS 
colonization and prolonged labour, P value of 0.00. 
In TABLE 5, The incidence of preterm labour in GBS positive 
women was analyzed. 
 Mc  Duffee  RS Jr,  Mc  Nabbs32 found that the incidence of preterm 
labour in GBS positive women was 13.00% 
 Feikin DR, Thorsen P et al42 found that the incidence of preterm 
labour in GBS positive women was 14.00% 
 Regan JA, Klebanoff, Nugent11 found that the incidence of preterm 
labour in GBS positive women was 14.70% 
 Joshi, Chen et al found that the incidence of preterm labour in GBS 
positive women was 15.60% 
 Regan Ja, Chau S et al22 found that the incidence of preterm labour 
in GBS positive women was 18.00% 
 Mc Donald, Vigneshwaran, O’ Loughlin23 found that the incidence 
of preterm labour in GBS positive women was 18.70% 
 CHS Chan, KM Wan, WH Lee27 found that the incidence of preterm 
labour in GBS positive women was 20.00% 
63 
 
 Koshelena et al36 found that the incidence of preterm labour in GBS 
positive women was 21.70% 
 Matorass R, Garecea percea39 found that the incidence of preterm 
labour in GBS positive women was  28.20% 
 Manuel et al28 found that the incidence of preterm labour in GBS 
positive women was 35.00% 
 Present study shows that the 3 patients ( 16.7%) who were colonized 
with the GBS positive went in for preterm labour whereas 15 ( 6.2%) 
patients who were not colonized with GBS developed preterm labour. 
 The association between preterm labour and GBS positive women 
was found to be statistically significant, P value 0.002 
 The incidence of preterm labour was found to be 7.5 times more 
common in patients colonized with GBS, than when compared to patients 
who were non-colonized. 
 In all the above references and the present study, the association 
between GBS positive and preterm labour found to be statistically 
significant. 
In TABLE 6, the incidence of Premature Rupture of Membrane in 
GBS positive women was analyzed. 
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 CHS Chan, KM Wan, WH Lee27 found that the incidence of PROM 
in GBS positive women was 14.20% 
 Koshelena et al Lee36 found that the incidence of PROM in GBS 
positive women was 13.70% 
 Mc Duffee RS Jr, Mc Nabbs Lee32 found that the incidence of 
PROM in GBS positive women was 13.00% 
 Mc Donald, Vigneshwaran, O’ Loughlin Lee23 found that the 
incidence of PROM in GBS positive women was 9.90% 
 Regan JA, Chau S, James Lee22 found that the incidence of PROM 
in GBS positive women was 8.10% 
 Present study shows that the 2 patients ( 25% ) who were colonized 
with the GBS Positive went in for PROM whereas 6 ( 2.5% ) patients who 
were not colonized with GBS developed PROM. 
 The association between PROM and GBS positive women was 
found to be statistically significant, P value of 0.001 
 In all the above references and the present study , the association 
between GBS positive and PROM found to be statistically significant. 
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In TABLE 7, Mode of delivery in study group was analyzed. 
 Katz et al35 found that the incidence of LSCS in GBS positive 
women was 42.4% 
 Liang ST, Lab BP, Fok TF25 found that the incidence of LSCS in 
GBS positive women was 49.2% 
 Present study shows the incidence of LSCS in GBS positive patients 
was found to be 55.6% and that in the GBS  negative group was found to 
be 17% 
 It was found that LSCS delivery is more common in GBS positive 
patients than in negative patients with P value of 0.003 
 In all the above references and the present study, the association 
between GBS Positive and LSCS found to be statistically significant. 
In TABLE 8, APGAR SCORE at one minute and five minute of all 
the babies born to the women under study were analyzed. 
 Gerards CJ, Lab BP, Hoog, Kamp Korstange JA37 in a study 
reported Low Apgar score in GBS positive women (10.2 % ) when 
compared to GBS negative women. 
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 CHS Chan, KM Wan , WH Lee27 found that the low Apgar score in 
GBS positive women ( 10% ) when compared to GBS negative women. 
 Present study shows the incidence of Low Apgar Score in GBS 
positive patients found to be 27.3 % and that in the GBS Negative group 
was found to be   3.3 % 
 It was found that Low Apgar score is more common in GBS positive 
patients than in Negative patients, P value of 
 In all the above references and the present study, the association 
between GBS positive and Low Apgar score found to be statistically 
significant. 
In TABLE 9, The Birth Weight of all the babies born to the women 
under study were analyzed. 
 Regan JA, Klebanoff, Nugent 11found that the percentage of Low 
Birth Weight in GBS positive women was 20.6% 
 Matorras, Garecea Percea et al39 found that the percentage of Low 
Birth Weight in GBS positive women was 20% 
 Gerards CJ, Hoog et al37 found that the percentage of Low Birth 
Weight in GBS positive women was 30.1% 
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 Present study shows the incidence of low birth  weight in GBS 
positive women was 60% 
 In all the above references and present study , the association 
between low birth weight and GBS Positive women, statistically 
significant. 
In TABLE 10, The percentage of NICU Admission in GBS positive 
women were analyzed. 
 Beyer KM33 found that the percentage of GBS infants admitted was 
10-20% 
 Chan CHS, KM Wan, WH Lee27 found that the percentage of GBS 
infants admitted was 12% 
 Gerards CJ, Lab BP37 found that the percentage of GBS infants 
admitted was 19.5% 
 Present study shows that the number of babies admitted in the 
neonatal intensive care unit in the Group B streptococcal positive group 
were 4 ( 30.8% )and in negative group were 9 ( 3.7% ) 
 There was Significant association between positive patients and the 
need for neonatal admission, P value 0.000 
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In TABLE 12, The Neonatal Sepsis in GBS positive was analyzed. 
 Regan JA, Klebanoff11  found that the rate of neonatal sepsis in GBS 
positive women was 26% 
 Liang, Lan SP, Fok TF25, found that the rate of neonatal sepsis in 
GBS positive women was 16% 
 CHS  Chan,  KM  Wan,  WH  Lee27 found that the rate of neonatal 
sepsis in GBS positive women was 13% 
 Boyer KM33 found that the rate of neonatal sepsis in GBS positive 
women was 18% 
 Katz et al35 found that the rate of neonatal sepsis in GBS positive 
women was 10-30% 
 Campbel et al38 found that the rate of neonatal sepsis in GBS 
positive women was 14% 
 Present study shows the incidence of neonatal sepsis in GBS 
positive women was  0.4 % 
In TABLE 12, THE NEONATAL MORTALITY was analyzed. 
 Beyer KM et al33 found that the rate of neonatal mortality in GBS 
positive women was 10-20% 
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 Koshelena et al36 found that the rate of neonatal mortality in GBS 
positive women was 12.6% 
 Campbel et al38 found that the rate of neonatal mortality in GBS 
positive women was 10.6% 
 Present study shows the incidence of neonatal mortality in GBS 
positive women was   0.4% 
 There was no statistical significance between GBS status of mother 
and neonatal mortality when compared among the two groups. 
In TABLE 13, Maternal Morbidity in GBS positive women was 
analyzed by way of post partum pyrexia, urinary tract infections, wound 
infection at the caesarean site and episiotomy wound etc., 
 Hastings et al44 found that the maternal morbidity in GBS positive 
women was 20%  
 Mc Duffee RS Jr, Mc Nabbs32 found that the maternal morbidity in 
GBS positive women was 35.6% 
 Present study shows the maternal morbidity in GBS positive women 
was 66.7  % 
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 There was statistical significance between the GBS status and 
Maternal Morbidity when compared among the two groups. 
 There was no Maternal Mortality in the study group of both the 
categories. 
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SUMMARY 
x The prevalence of group B streptococcal colonization in 
asymptomatic primi gravida in the study population was 3.6% 
x The maternal colonization with group B streptococci was not related 
to age, and socio economic status of the patients. 
x There was an increased incidence of preterm labour (16.7%) in 
patients colonized with group B streptococci, when compared to 
those who were not colonized (6.2%). 
x There was an increased incidence of Prmature Rupture of 
membranes (25.0%) in patients colonized with group B streptococci, 
when compared to those who were not colonized (2.5%). 
x There was an increased incidence of prolonged labour (55.6%), 
among the positive group when compared to the negative group 
(3.3%) . 
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x There was an increased incidence of low APGAR scores among 
babies born to positive women than when compared to negative 
women. 
x There was an increased incidence of operative deliveries (LSCS) 
among GBS colonized women (55.6%) than when compared to GBS 
negative women  (17.0%). 
x There was statistically significant, increased rate of neonatal 
admissions (30.8%)  to babies born to GBS positive mothers than in 
the negative group (3.7%). 
x The mortality rate of the neonates in the GBS positive group was 
0.4%. This low rate could be due to the improved neonatal care 
available at our institution. 
x There was significant maternal morbidity (analyzed in terms of 
fever, wound infections etc.,) in GBS positive group (66.7%), when 
compared to GBS negative group (33.3%). 
x There was no maternal mortality in both the groups. 
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From the above statements it could be inferred that the screening of 
all the pregnant women at 37-38 weeks of gestation, serves to be an 
important factor in reducing the incidence of preterm labour, premature 
rupture of membranes, prolonged labour, operative deliveries and hence 
decrease the probability of low birth weight, low APGAR scores, and 
hence subsequent morbidity and mortality of both the mother and the 
newborn. 
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CONCLUSION 
a.  The prevalence of Group B streptococcus infection at 35-37 weeks 
of gestation in normal, asymptomatic primi gravida attending the 
routine antenatal clinic in a level three tertiary care institution  
is 3.6% 
b.  The incidence of preterm labour in GBS colonized women is 16.7%, 
and in non colonized women is 6.2%. There is statistically 
significant increased risk of preterm labour in GBS positive women. 
c.  The incidence of premature rupture of membranes in colonized 
women is 25.0% and in non colonized women is 2.5%. The 
association of premature rupture of membranes and GBS positive 
status is statistically significant. 
d.  The incidence of prolonged labour in colonized women is 55.6%  
and in non colonized women is 3.3%. The association of prolonged 
labour and GBS positive status is statistically significant. 
e.  There is statistically increased incidence of operative deliveries 
(55.6%) in GBS positive women, when compared to negative 
women. (17.0%). 
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f.  The puerperal morbidity in GBS positive women is 66.7%, and in 
negative women is 33.3%. There is significant increased puerperal 
morbidity in GBS positive women. 
g.  There is statistically significant increase in neonatal morbidity in the 
form of increased neonatal admissions in GBS positive women 
(30.8%), when compared to GBS negative women. (3.7%). 
h.  The neonatal mortality rates were not significant (1/9 babies) in 
babies born to GBS positive patients when compared to GBS 
negative patients.(2/241 babies). 
All the above conclusions, point out the importance of GBS 
screening during the antenatal period and the need to include it in the 
screening protocol of our health systems in the present era of evidence 
based medicine. 
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PROFORMA 
 
NAME: 
AGE: 
IP NO: 
SOCIOECONOMIC STATUS: 
GA: 
LMP: 
EDD: 
MENSTRUAL H/O: 
MARITAL H/O: 
OBSTETRIC H/O: 
PAST H/O: 
VITALS: 
TEMP- 
BP- 
PULSE RATE- 
GENERAL EXAMINATION: 
HEIGHT: 
WEIGHT: 
BMI: 
CARDIOVASCULAR EXAMINATION: 
RESPIRATORY EXAMINATION: 
OBSTETRIC EXAMINATION: 
INVESTIGATION: 
Hb- 
URINE ALBUMIN,- 
               SUGAR- 
BLOOD SUGAR- 
BLOOD UREA- 
BLOOD GROUPING AND TYPING- 
HIV- 
VDRL- 
HbSAg- 
USG- 
MATERNAL OUTCOME: 
MODE OF ONSET OF LABOUR- 
PROLONGED LABOUR- 
PRETERM LABOUR- 
PROM-  
MODE OF DELIVERY- 
MATERNAL MORBIDITY- 
FETAL OUTCOME: 
APGAR SCORE- 
BIRTH WEIGHT- 
NICU ADMISSION- 
INDICATION OF NICU ADMISSION- 
NEONATAL MORTALITY- 
 
 
 
 
 
S.No. Name Age/IP No. LMP EDD GA SES
Mode of 
onset of labour
Prolonged 
labour 
Mode of 
Delivery
Preterm 
Labour
PROM
Birth 
Weight (K.G)
NICU 
Admission
Indication for 
Neonatal 
Admission
Neonatal 
Mortality
Maternal 
Morbidity
GBS
1" 5"
1 Nadhiya 20/9284 22.01.11 29.08.12 36 L Spontaneous No Vaginal Yes No 8 8 1.9 YES LBW LBW
YES 
(SEPSIS)       - POSITIVE
2 Revathy 26/9282 23.12.11 30.09.12 38 L Induction No Vaginal NO No 8 8 3.3 NO NO NO       - (-ve)
3 Pachiammal 24/9253 07.01.12 14.10.12 37 L Spontaneous No Vaginal NO No 9 8 2.4 NO NO NO       - (-ve)
4 Jayalakshmi 27/9281 04.09.11 11.08.12 38 L Spontaneous No Vaginal NO No 8 9 2.3 NO NO NO       - (-ve)
5 Yasmin 24/9288 14.02.11 21.11.12 38 M Spontaneous No Vaginal NO No 8 9 3.15 NO NO NO       - (-ve)
6 Kanchana 20/9251 01.02.11 08.11.12 36 L Spontaneous No Vaginal NO No 9 8 2.2 NO NO NO       - (-ve)
7 Saraswathy 19/9239 21.01.12 28.10.12 35 L Spontaneous No Vaginal Yes No 8 8 2.0 YES LBW LBW NO       - (-ve)
8 Savitha 24/9291 13.02.11 20.11.12 36 M Spontaneous No Vaginal NO No 8 8 2.2 NO NO       - (-ve)
9 Tamil Selvi 16/8700 15.11.11 22.08.12 37 L Spontaneous No LSCS NO No 8 8 2.4 NO NO       - (-ve)
10 Parvathy 27/9315 04.12.11 11.09.12 37 L Spontaneous No Vaginal NO No 7 9 2.5 NO NO       - (-ve)
11 Jothi 19/9324 11.02.12 18.11.12 38 M Spontaneous No Vaginal NO No 9 8 3.25 NO NO       - (-ve)
12 Sowmiya 19/9314 22.01.12 29.10.12 38 L Spontaneous No Vaginal NO No 9 8 2.6 NO NO       - (-ve)
13 Mala 23/9317 12.01.12 19.10.12 38 M Spontaneous No Vaginal NO No 8 8 2.8 NO NO       - (-ve)
14 Muniamma 19/9322 17.11.11 24.08.12 38 M Spontaneous No Vaginal NO No 8 8 2.8 NO NO       - (-ve)
15 Aruna 20/9256 06.02.11 13.11.12 37 L Induction No Vaginal NO No 8 8 2.6 NO NO       - (-ve)
16 Tamil Selvi 19/9287 04.01.12 11.10.12 37 L Spontaneous No Vaginal NO No 8 8 2.8 NO NO       - (-ve)
17 Arul 19/9309 04.09.11 11.08.12 37 L Spontaneous No Vaginal Yes No 8 8 2.7 NO NO       - (-ve)
18 Saraswathy 19/9300 12.02.11 19.11.12 38 L Induction   - Vaginal  -  - 8 9 2.8 NO  -  -       - (-ve)
19 Divya 20/9206 26.03.12 03.12.12 39 L Spontaneous   - Vaginal  -  - 8 8 3.2 NO  -  -       - (-ve)
20 Anitha 21/9323 27.03.12 04.12.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.4 NO  -  -       - (-ve)
21 Sumathy 22/9286 08.11.11 15.08.12 37 L Induction   - Vaginal  -  - 7 8 2.4 NO  -  -       - (-ve)
22 Maliga 19/9304 13.09.11 20.08.12 38 M Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -       - (-ve)
23 Umar Mageshwari 24/9269 04.01.12 11.10.12 38 M Spontaneous   - Vaginal  -  - 8 8 3.2 NO  -  -       - (-ve)
24 Sathya 23/9322 09.02.11 16.11.12 38 L Spontaneous   - LSCS  -  - 9 9 3.0 NO  -  -       - (-ve)
25 Mohana 20/9331 20.02.11 28.11.12 37 L Spontaneous   - Vaginal  -  - 9 9 2.8 NO  -  -       - (-ve)
26 Salme Begum 22/9357 17.11.11 24.08.12 38 L Spontaneous   - Vaginal  -  - 8 8 3.1 NO  -  -       - (-ve)
27 Nirosha 19/9269 08.10.11 15.07.12 38 L Spontaneous   - Vaginal  -  - 9 9 2.3 NO  -  -       - (-ve)
28 Mahalakshmi 21/9388 04.09.11 11.08.12 38 L Spontaneous yes
Instrumental
outlet  - yes 7 8 2.8 NO  -  - FEVER POSITIVE
29 Ilavarasi 20/9343 01.11.11 08.08.12 35 L Spontaneous   - Vaginal Yes  - 9 9 2.4 NO  -  -       - (-ve)
30 Karpagam 23/9391 02.12.11 09.09.12 37 M Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -       - (-ve)
31 Rhmathnisha 21/9385 24.09.11 31.08.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -       - (-ve)
32 Subhashini 20/9231 28.02.11 05.11.12 38 L Spontaneous   - LSCS  -  - 8 8 3.0 NO  -  -       - (-ve)
33 Kuppulakshmi 21/9268 26.01.12 02.10.12 39 L Induction   - Vaginal  -  - 9 9 2.9 NO  -  -       - (-ve)
34 Shanthi 26/9275 23.12.11 30.09.12 39 L Induction   - Vaginal  -  - 8 8 3.2 NO  -  -  - (-ve)
35 Sharmila 25/9295 08.10.11 15.07.12 38 L Spontaneous   - LSCS  -  - 8 8 2.6 NO  -  -  - (-ve)
36 Sumathi 19/9333 04.09.11 11.08.12 38 M Spontaneous   - Vaginal  -  - 8 8 2.4 NO  -  -  - (-ve)
37 Uma 21/9379 01.13.12 08.12.12 38 M Spontaneous   - Vaginal  -  - 8 8 2.5 NO  -  -  - (-ve)
38 Mohana 22/9330 16.12.11 23.09.12 37 M Induction yes LSCS  -  - 7 8 2.4 YES LBW  -  - POSITIVE
39 Vijayalakshmi 25/9381 06.09.11 13.08.12 36 L Spontaneous   - Vaginal Yes  - 8 8 2.4 NO  -  -  - (-ve)
40 Menaka 23/9416 18.02.11 25.11.12 38 L Spontaneous   - Vaginal  -  - 8 8 3.15 NO  -  -  - (-ve)
Apgar
MASTER CHART
41 Ammurani 24/9376 09.11.11 16.08.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -  - (-ve)
42 Manimala 25/9420 23.01.12 30.10.12 37 L Spontaneous   - Vaginal  -  - 9 9 2.8 NO  -  -  - (-ve)
43 Thiruveni 22/9355 22.12.11 29.09.12 39 L Spontaneous   - Vaginal  -  - 9 9 3.25 NO  -  -  - (-ve)
44 Sangeetha 23/9419 17.02.11 24.11.12 38 M Spontaneous   - Vaginal  -  - 7 9 2.7 NO  -  -  - (-ve)
45 Nandhini 19/9352 23.02.11 30.11.12 38 M Spontaneous   - Vaginal  -  - 8 8 3.2 NO  -  -  - (-ve)
46 Noorhabiba 22/9344 21.02.11 28.11.12 37 L Induction   - Vaginal  -  - 8 9 2.75 NO  -  -  - (-ve)
47 Parvathy 22/9431 13.12.11 20.09.12 38 L Spontaneous   - LSCS  -  - 8 9 2.9 NO  -  -  - (-ve)
48 Pricills 24/9452 13.09.11 20.08.12 37 M Spontaneous   - Vaginal  -  - 8 8 2.32 NO  -  -  - (-ve)
49 Bharathi 22/9448 01.01.12 08.10.12 38 M Spontaneous   - Vaginal  -  - 8 9 3.0 NO  -  -  - (-ve)
50 Kavitha 19/9473 05.11.11 12.08.12 39 L Induction   - LSCS  -  - 9 9 2.9 NO  -  -  - (-ve)
51 Latha 20/9488 15.12.11 22.09.12 34 L Spontaneous   - Vaginal Yes  - 7 8 2.3 NO  -  -  - (-ve)
52 Keerthana 18/9921 21.12.11 28.09.12 38 L Spontaneous   - Vaginal  -  - 9 9 3.2 NO  -  -  - (-ve)
53 Jagadeeshwari 19/9497 13.02.11 20.01.12 38 M Induction   - Vaginal  -  - 9 9 2.9 NO  -  -  - (-ve)
54 Dharani 30/9493 24.03.12 01.12.12 38 M Spontaneous   - Vaginal  -  - 8 8 2.9 NO  -  -  - (-ve)
55 Anjali 22/9506 09.11.11 16.08.12 39 L Spontaneous   - Vaginal  -  - 8 9 3.2 NO  -  -  - (-ve)
56 Kanchana 19/9524 09.02.11 16.11.12 37 L Spontaneous   - Vaginal  -  - 9 9 2.2 NO  -  -  - (-ve)
57 Nandhini 20/9521 22.02.11 29.11.12 37 M Spontaneous   - LSCS  -  - 8 8 2.7 NO  -  -  - (-ve)
58 Sherin 19/9499 21.11.11 28.08.12 38 M Spontaneous   - Vaginal  -  - 9 9 3.1 NO  -  -  - (-ve)
59 Nandhini 20/9567 04.01.12 11.10.12 38 L Spontaneous   - Vaginal  -  - 8 9 2.8 NO  -  -  - (-ve)
60 Yamuna 19/9515 10.12.11 07.09.12 36 L Spontaneous yes Vaginal Yes  - 4 7 2.4 YES
FETAL 
DISTRESS  - 
Wound
infection POSITIVE
61 Paween Fathima 21/9588 24.09.11 31.08.12 38 L Induction   - Vaginal  -  - 8 9 2.6 NO  -  -  - (-ve)
62 Sangeetha 20/9525 20.02.11 27.11.12 37 L Spontaneous   - Vaginal  -  - 8 9 2.3 NO  -  -  - (-ve)
63 Anitha 21/9582 04.12.11 11.09.12 38 L Spontaneous   - LSCS  -  - 8 9 2.8 NO  -  -  - (-ve)
64 Bommi 26/2578 02.01.12 09.10.12 37 L Spontaneous   - Vaginal  -  - 9 9 2.4 NO  -  -  - (-ve)
65 Suguna 20/9604 30.03.12 07.12.12 38 L Induction   - Vaginal  -  - 8 8 2.9 NO  -  -  - (-ve)
66 Shakila begum 20/9616 12.12.11 19.09.12 38 L Spontaneous   - Vaginal  -  - 9 9 3.3 NO  -  -  - (-ve)
67 Shanthi 18/9610 08.10.11 15.07.12 39 L Spontaneous   - Vaginal  -  - 9 9 3.0 NO  -  -  - (-ve)
68 Srikala 23/9629 06.02.11 13.11.12 37 M Spontaneous   - Vaginal  -  - 8 8 2.4 NO  -  -  - (-ve)
69 Nalini 23/9551 13.02.11 20.11.12 37 L Spontaneous yes LSCS  -  - 4 7 2.9 NO  -  -  - POSITIVE
70 Soapna 19/9624 21.02.11 28.11.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.4 NO  -  -  - (-ve)
71 Devi 22/9539 24.09.11 31.08.12 38 L Induction   - Vaginal  -  - 8 8 2.6 NO  -  - Fever (-ve)
72 Varlakshmi 19/9653 04.03.11 11.12.12 39 M Spontaneous   - LSCS  -  - 8 8 3.6 NO  -  -  - (-ve)
73 Roja 19/9674 21.01.12 28.10.12 38 M Spontaneous   - Vaginal  -  - 7 7 2.8 NO  -  -  - (-ve)
74 Revathy 20/9455 13.01.12 20.10.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.4 NO  -  -  - (-ve)
75 Thaveega 18/9682 08.02.11 15.11.12 38 L Spontaneous   - LSCS  -  - 8 8 2.7 NO  -  -  - (-ve)
76 Bharathi 23/9695 20.02.11 27.11.12 38 L Induction   - Vaginal  -  - 8 8 2.9 NO  -  -  - (-ve)
77 Gowri 22/9715 08.10.11 15.07.12 37 M Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -  - (-ve)
78 Sagammal 18/9723 05.12.11 12.09.12 39 M Spontaneous   - Vaginal  -  - 8 8 3.25 NO  -  -  - (-ve)
79 Vaedamani 25/9686 04.01.12 11.10.12 37 L Spontaneous   - LSCS  -  - 8 9 2.4 NO  -  -  - (-ve)
80 Sumaya Begum 19/9788 12.12.11 19.09.12 37 L Spontaneous   - Vaginal  -  - 8 9 2.7 NO  -  -  - (-ve)
81 Amudha 22/9777 24.01.12 31.10.12 38 M Spontaneous   - Vaginal  -  - 7 9 2.8 NO  -  -  - (-ve)
82 Kalaiselvi 21/6036 23.02.11 30.11.12 38 L Spontaneous   - Vaginal  -  - 8 9 3.6 NO  -  -  - (-ve)
83 Bharathi 27/6040 01.11.11 08.08.12 38 L Spontaneous   - Vaginal  -  - 8 9 2.9 NO  -  -  - (-ve)
84 Karpagam 21/6050 06.01.12 13.10.12 38 M Induction   - LSCS  -  - 9 9 3.12 NO  -  -  - (-ve)
85 Jaynthi 20/6051 13.02.11 20.11.12 37 M Spontaneous   - Vaginal  -  - 9 9 3.0 NO  -  -  - (-ve)
86 Tanizh 21/6028 04.08.11 12.05.12 36 L Spontaneous   - Vaginal Yes  - 8 8 2.3 NO  -  -  - (-ve)
87 Usha 19/6032 02.11.11 09.08.11 37 L LSCS   - LSCS  -  - 8 8 2.5 NO  -  -  - POSITIVE
88 Magheswari 22/6058 01.12.11 08.09.12 39 L Induction   - Vaginal  -  - 8 8 3.3 NO  -  -  - (-ve)
89 Aarathi 20/6055 08.12.11 15.09.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.4 NO  -  -  - (-ve)
90 Maegala 20/5994 20.01.12 27.10.12 38 M Spontaneous   - LSCS  -  - 8 8 2.9 NO  -  -  - (-ve)
91 saguntalai 21/6043 08.10.11 15.07.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.4 NO  -  -  - (-ve)
92 sumathi 21/6048 26.09.11 02.06.12 38 L Spontaneous   - Vaginal  -  - 7 7 2.9 NO  -  -  - (-ve)
93 Subbashini 22/6052 18.02.11 25.11.12 39 M Spontaneous   - LSCS  -  - 8 9 3.1 NO  -  -  - (-ve)
94 Valli 22/6079 13.12.11 20.09.12 38 M Induction   - Vaginal  -  - 8 9 2.9 NO  -  -  - (-ve)
95 Rihana 19/6131 04.01.12 11.10.12 38 L Spontaneous   - Vaginal  -  - 9 9 3 NO  -  -  - (-ve)
96 VasanthaPriya 21/6179 11.02.12 18.11.12 36 L Spontaneous   - Vaginal Yes - 9 9 2.3 NO  -  -  - (-ve)
97 Sumathi 20/6139 01.11.11 08.08.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -  - (-ve)
98 Kasthoori 20/6144 17.12.11 24.09.12 36 L Spontaneous   - Vaginal  -  - 8 8 2.3 NO  -  -  - (-ve)
99 Radhika 22/6086 06.02.11 13.11.12 38 M Spontaneous   - Vaginal  -  - 8 9 2.8 NO  -  -  - (-ve)
100 Annapoorni 20/6134 26.03.12 03.12.12 38 L Induction   - LSCS  -  - 9 9 3.4 NO  -  -  - (-ve)
101 Bhavani 21/6050 20.02.11 27.09.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.3 NO  -  -  - (-ve)
102 Imalatha 22/6126 28.03.11 05.12.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.7 NO  -  -  - (-ve)
103 Surya Kala 27/6178 24.09.11 31.08.12 38 L Induction   - LSCS  -  - 8 8 2.5 NO  -  -  - POSITIVE
104 Eswari 25/6191 05.01.12 12.10.12 37 M Induction yes LSCS  -  - 8 8 2.5 NO  -  -  - POSITIVE
105 Muniamma 22/6210 15.11.11 22.08.12 37 M Spontaneous   - Vaginal  -  - 9 9 2.4 NO  -  -  - (-ve)
106 Savitha 25/6206 06.12.11 13.09.12 38 M Spontaneous   - Vaginal  -  - 9 9 2.7 NO  -  -  - (-ve)
107 Suganya 20/6249 11.12.11 18.09.12 38 L Spontaneous   - LSCS  -  - 8 8 3.3 NO  -  -  - (-ve)
108 Sasikala 22/6227 20.12.11 27.09.12 38 L Spontaneous   - Vaginal  -  - 9 9 2.6 NO  -  -  - (-ve)
109 Nagalakshmi 25/6250 08.10.11 15.07.12 38 M Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -  - (-ve)
110 Saranya 19/6247 16.11.11 23.08.12 39 M Spontaneous   - LSCS  -  - 8 8 3.4 NO  -  -  - (-ve)
111 Nadhiya 23/6218 12.01.12 19.10.12 37 L Spontaneous   - Vaginal  -  - 7 7 2.3 NO  -  -  - (-ve)
112 Padma 23/6257 24.03.12 01.12.12 38 L Induction   - Vaginal  -  - 8 8 2.6 NO  -  -  - (-ve)
113 Pavithra 30/6262 06.09.11 13.08.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -  - (-ve)
114 Aadhilakshmi 22/6245 20.02.11 27.11.12 36 L Spontaneous   - Vaginal Yes  - 8 8 2.6 NO  -  -  - (-ve)
115 Kalpana 21/6254 12.12.11 19.09.12 37 M Spontaneous   - Vaginal  -  - 8 8 2.2 YES LBW LBW  -  - (-ve)
116 Jayachitra 29/6303 05.11.11 12.08.12 38 L Spontaneous   - LSCS  -  - 8 8 3.5 NO  -  -  - (-ve)
117 Kumudha 19/6348 04.02.11 11.11.12 38 L Spontaneous   - Vaginal  -  - 4 7 2.8 NO  -  -  - (-ve)
118 Yamuna 18/6503 26.09.11 02.06.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.6 NO  -  -  - (-ve)
119 Kavitha 22/6487 21.11.11 28.08.12 39 L Spontaneous   - Vaginal  -  - 8 9 3.4 NO  -  -  - (-ve)
120 Devi 21/6493 15.01.12 22.10.12 38 M Spontaneous   - Vaginal  -  - 9 9 2.7 NO  -  -  - (-ve)
121 Lakhsmi 24/6507 17.11.11 24.08.12 38 M Induction   - Vaginal  -  - 9 9 2.4 NO  -  -  - (-ve)
122 Kanchana 26/6525 18.12.11 25.09.12 36 LOWER Spontaneous   - Vaginal Yes  - 8 8 2.3 NO  -  -  - (-ve)
123 Arulmozhi 23/6527 10.01.12 17.10.12 38 LOWER Spontaneous   - LSCS  -  - 8 9 2.8 NO  -  -  - (-ve)
124 Saranya 23/6529 14.11.11 21.08.12 39 LOWER Spontaneous   - Vaginal  -  - 7 7 3.2 NO  -  -  - (-ve)
125 Rabecca 25/6532 15.01.12 22.10.12 38 MIDDLE Induction   - Vaginal  -  - 9 9 2.7 NO  -  -  - (-ve)
126 Sumathi 31/6573 04.12.11 11.09.12 39 LOWER Spontaneous   - Vaginal  -  - 9 9 3.12 NO  -  -  - (-ve)
127 Jaya 21/6231 23.02.11 30.11.12 38 LOWER Spontaneous   - LSCS  -  - 8 8 2.8 NO  -  -  - (-ve)
128 Ammu 19/6586 06.12.11 13.09.12 37 MIDDLE Spontaneous   - Vaginal  -  - 8 9 2.2 NO  -  -  - (-ve)
129 Kavitha 21/6586 14.01.12 21.10.12 38 MIDDLE Induction   - Vaginal  -  - 8 9 2.9 NO  -  -  - (-ve)
130 Kamala 23/6579 08.10.11 15.07.12 38 L Spontaneous   - Vaginal  -  - 8 9 2.8 NO  -  -  - (-ve)
131 Poongodi 26/6538 11.01.12 18.10.12 39 L Spontaneous   - Vaginal  -  - 9 9 3.2
YES 
FETELDISTR
ESS
FETAL 
DISTRESS  -  - (-ve)
132 Manimala 23/6616 11.11.11 18.08.12 38 M Spontaneous   - Vaginal  -  - 9 9 2.7 NO  -  -  - (-ve)
133 Parimala 24/6611 18.01.12 25.10.12 39 L Spontaneous   -
INSTRUIMENTA
L  -  - 9 9 3.15 NO  -  -  - (-ve)
134 Yasmin 22/6639 23.11.11 30.08.12 38 L Induction   - Vaginal  -  - 8 8 2.4 NO  -  -  - (-ve)
135 Mithra 23/6277 06.02.11 13.11.12 36 L Spontaneous   - Vaginal Yes  - 8 9 2.4 NO  -  -  - (-ve)
136 Subhashini 29/6643 02.02.11 09.11.12 37 L Spontaneous   - Vaginal  -  - 8 9 2.7 NO  -  -  - (-ve)
137 Vanitha 22/6434 26.03.12 03.12.12 37 M Spontaneous   - Vaginal  -  - 9 9 2.8 NO  -  -  - (-ve)
138 Thangamani 26/6645 28.03.12 05.12.12 37 M Spontaneous   - Vaginal  -  - 9 9 2.8 NO  -  -  - (-ve)
139 Tamilarasi 24/6640 30.03.12 07.12.12 38 M Spontaneous yes LSCS  -  - 8 9 3 NO  -  -  - (-ve)
140 Uma Maheswari 23/6607 22.01.12 29.10.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.5 NO  -  -  - (-ve)
141 Bhuvaneshwai 23/6153 18.11.11 25.08.12 37 L Spontaneous   - LSCS  - YES 8 9 2.8 NO  -  -  - (-ve)
142 Jimmaalati 22/6126 09.01.12 16.10.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.6 NO  -  -  - (-ve)
143 Surya Kala 21/6178 26.09.11 22.06.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.6 NO  -  -  - (-ve)
144 Chitra 22/6180 12.02.11 19.11.12 39 L Induction   - LSCS  -  - 8 9 3.6 NO  -  -  - (-ve)
145 Divya 21/6688 11.02.11 18.11.12 36 M Spontaneous   - Vaginal  -  - 8 8 2.2 NO  -  -  - (-ve)
146 Naseema 27/6083 22.02.11 27.11.12 37 M Spontaneous   - Vaginal  -  - 8 9 2.8 NO  -  -  - (-ve)
147 Kalpana 21/6218 15.12.11 22.09.12 38 M Spontaneous yes
INSTRUIMENTA
L  -  - 4 7 2.7
YES FETAL
 DISTRES
FETAL
DISTRESS YES MAS (-ve)
148 Saranya 21/6694 01.02.11 08.09.12 39 L LSCS   - LSCS  -  - 8 9 3.4 NO  -  -  - (-ve)
149 Sudhalakshmi 25/6694 24.09.11 31.08.12 37 L Spontaneous   - Vaginal  -  - 8 9 2.1 NO  -  -  - (-ve)
150 Bharathi 22/6596 08.02.11 15.11.12 37 L Spontaneous   - Vaginal  -  - 9 9 2.6 NO  -  -  - (-ve)
151 Devi 21/6726 10.11.11 17.08.12 38 M Spontaneous   - LSCS Yes  - 8 8 3.3 NO  -  -  - (-ve)
152 Shajitha Banu 18/6734 16.02.11 23.11.12 37 M Spontaneous   - Vaginal  -  - 8 8 2.2 NO  -  -  - (-ve)
153 Ishwarya 19/6729 19.02.11 16.09.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -  - (-ve)
154 Bhavani 23/6632 01.01.12 08.10.12 37 L Spontaneous   - Vaginal  -  - 6 7 2.4 NO  -  -  - (-ve)
155 Ponmani 26/6799 23.01.12 30.10.12 38 L Induction   - Vaginal  -  - 9 9 2.7 NO  -  -  - (-ve)
156 Pushpa 23/6518 23.02.11 30.11.12 39 L Spontaneous   - LSCS  -  - 9 9 3.5 NO  -  -  - (-ve)
157 Amsaveni 23/6785 20.12.11 27.09.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -  - (-ve)
158 Kumudha 23/6820 06.02.11 13.11.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.5 NO  -  -  - (-ve)
159 Kavitha 19/4669 04.01.12 11.10.12 36 L Spontaneous   - Vaginal Yes  - 8 8 2.5 NO  -  -  - (-ve)
160  Rubinishi 24/4719 14.12.11 21.09.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.9 NO  -  -  - (-ve)
161 Bhawani 20/4713 08.01.12 15.10.12 37 M Spontaneous   - Vaginal  -  - 4 7 2.4 NO  -  -  - (-ve)
162 Chitra 26/4704 06.02.11 13.11.12 38 M Spontaneous   - Vaginal  -  - 8 8 2.9 NO  -  -  - (-ve)
163 Anitha 25/4729 15.01.12 22.10.12 39 M Induction   - Vaginal  -  - 8 9 2.5 NO  -  -  - (-ve)
164 Ranga 19/4803 07.11.11 14.08.12 39 M Spontaneous   - Vaginal  -  - 9 9 2.8 NO  -  -  - (-ve)
165 Punidha 21/4742 06.09.11 13.08.12 40 M Spontaneous yes LSCS  -  - 8 9 3.6 YES
MOTHER
DIABETIC  -  - (-ve)
166 Padma Priya 23/4809 03.02.11 10.11.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.6 NO  -  -  - (-ve)
167 Lavanya 20/4789 21.01.12 28.10.12 37 L Spontaneous   - Vaginal  -  - 8 9 2.5 NO  -  -  - (-ve)
168 Vanitha 22/4808 04.12.11 11.09.12 39 M Spontaneous   - LSCS  -  - 9 9 3.8 NO  -  -  - (-ve)
169 Alamelu 19/4834 01.11.11 08.08.12 38 L Induction   - Vaginal  -  - 9 9 2.7 NO  -  -  - (-ve)
170 Radhi 23/4827 28.03.12 05.12.12 37 L Spontaneous   - Vaginal  -  - 8 9 2.5 NO  -  -  - (-ve)
171 Roopadevi 23/4278 09.11.11 16.08.12 38 M Spontaneous   - Vaginal Yes  - 8 8 2.8 NO  -  -  - (-ve)
172 Bhavani 19/4825 12.12.11 19.09.12 39 L Spontaneous   - LSCS  -  - 9 9 3.4 NO  -  -  - (-ve)
173 Amulu 21/4828 07.02.11 14.11.12 38 L Induction   - Vaginal  -  - 9 9 2.7 NO  -  -  - (-ve)
174 Aathi 20/4821 11.11.11 18.08.12 37 M Spontaneous   - Vaginal  -  - 8 8 2.4 NO  -  -  - (-ve)
175 Radha 21/4837 20.11.11 27.08.12 37 M Spontaneous   - Vaginal  - YES 9 9 2.5 NO  -  -  - (-ve)
176 Anitha 20/4830 10.02.11 17.11.12 40 L Induction   - LSCS  -  - 8 8 3.2 NO  -  -  - (-ve)
177 Radha 21/4850 02.11.11 09.08.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.4 NO  -  -  - (-ve)
178 Rajasudha 20/4632 16.01.12 23.10.12 38 M Spontaneous   - Vaginal  -  - 8 9 2.6 NO  -  -  - (-ve)
179 Sharmila 19/4805 06.12.11 13.09.12 38 M Induction   - LSCS  -  - 8 9 3.2
yes 
fetal 
distress
FETAL 
DISTRESS  -  - (-ve)
180 Vasuki 20/4795 05.11.11 12.08.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -  - (-ve)
181 Sangeetha 23/4801 21.01.12 28.10.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.7 NO  -  -  - (-ve)
182 Ponmani 19/4838 28.03.12 05.12.12 36 L Spontaneous   - Vaginal  -  - 4 7 2.4 NO  -  -  - (-ve)
183 Amala 22/4683 15.02.11 22.11.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.9 NO  -  -  - (-ve)
184 Deepa 21/4746 08.10.11 15.07.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.7 NO  -  -  - (-ve)
185 Gowri 25/4637 20.11.11 27.08.12 38 M Induction   - Vaginal  -  - 8 8 2.5 NO  -  -  - (-ve)
186 Priyadharshini 19/4871 22.01.12 29.10.12 39 L Spontaneous yes LSCS  -  - 9 9 3.6
yes mother
hypothgal hypothigal  -  - (-ve)
187 Dhivya 21/4869 09.01.12 10.10.12 37 M Spontaneous   - Vaginal  -  - 8 8 2.6 NO  -  -  - (-ve)
188 Sangeetha 20/4877 07.12.11 14.09.12 37 M Spontaneous   - Vaginal  -  - 8 8 2.5 NO  -  -  - (-ve)
189 Sheela 26/4842 01.03.12 08.12.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.6 NO  -  -  - (-ve)
190 Rajinamary 25/4867 19.02.11 26.11.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.4 NO  -  -  - (-ve)
191 Geetha 20/4390 04.09.11 11.08.12 37 L Spontaneous   - Vaginal  -  - 9 9 2.8 NO  -  -  - (-ve)
192 Rajashree 26/4843 11.01.12 18.10.12 37 M Induction   - Vaginal  -  - 9 9 2.4 NO  -  -  - (-ve)
193 Desamma 28/4881 05.02.11 12.11.12 37 M Spontaneous   - Vaginal  - YES 8 8 2.6 NO  -  -  - (-ve)
194 Devi 19/4860 23.11.11 30.08.12 38 M Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -  - (-ve)
195 Mageshwari 23/4639 20.12.11 27.09.12 37 L Induction   - Vaginal  -  - 8 8 2.7 NO  -  -  - (-ve)
196 mNehrija 26/1887 12.01.12 19.10.12 37 L Spontaneous   - Vaginal  -  - 8 9 2.6 NO  -  -  - (-ve)
197 Revathy 20/4815 17.01.12 24.10.12 37 M Spontaneous   - Vaginal  -  - 4 4 2.5 NO  -  -  - (-ve)
198 Hemavathy 21/4675 21.11.11 28.08.12 38 L Spontaneous   - Vaginal  -  - 9 9 2.8 NO  -  -  - (-ve)
199 Thilagavathy 26/4897 21.01.12 28.10.12 37 L LSCS   - LSCS  -  - 9 9 2.6 NO  -  -  - (-ve)
200 Selvi 20/4919 20.02.11 27.11.12 37 M Spontaneous   -
Instrumental
 -  - 8 8 2.7 NO  -  -  - (-ve)
201 Kanchana 17/4928 01.02.11 08.11.12 38 L Induction   - Vaginal  -  - 8 8 2.8 NO  -  -  - (-ve)
202 Shobana 19/4914 18.01.12 25.10.12 37 L Spontaneous   - Vaginal Yes  - 8 8 2.5 NO  -  -  - (-ve)
203 Indira Priyadharshini 24/4722 30.03.12 07.12.12 38 M Spontaneous   - Vaginal  -  - 8 8 2.9 NO  -  -  - (-ve)
204 Kalpana 28/4872 16.02.11 23.11.12 37 M Induction   - Vaginal  -  - 4 7 2.6 NO  -  -  - (-ve)
205 Kasthuribai 30/4923 03.02.11 10.11.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -  - (-ve)
206 Anandhavalu 36/4929 19.11.11 26.08.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.9 NO  -  -  - (-ve)
207 Anitha 27/4899 24.09.11 31.08.12 38 L Spontaneous   - Vaginal  -  - 9 9 2.7 NO  -  -  - (-ve)
208 Radhika 21/4875 04.01.12 11.10.12 38 L Spontaneous yes LSCS  -  - 8 8 2.9 NO  -  -  - (-ve)
209 Kalpana 18/4920 06.02.11 13.11.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -  - (-ve)
210 Sudha 18/4894 15.01.12 22.10.12 36 M Spontaneous   - Vaginal Yes  - 8 9 2.6 NO  -  -  - (-ve)
211 Rastha 19/4933 25.03.12 02.12.12 38 M Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -  - (-ve)
212 Radhika 19/4907 04.09.11 11.08.12 37 M Spontaneous   - Vaginal  -  - 8 8 2.5 NO  -  -  - (-ve)
213 Muthu Bhavani 23/4883 03.11.11 10.08.12 39 L Spontaneous   - Vaginal  -  - 8 8 2.9 NO  -  -  - (-ve)
214 Devi 21/4892 24.09.11 31.08.12 39 M Induction   - LSCS  -  - 8 8 2.9 NO  -  -  - (-ve)
215 Poogulazhi 23/4927 08.02.11 15.11.12 38 L Spontaneous   - Vaginal  -  - 9 9 2.8 YES WEAK CRY
YES 
METABOLIC 
CAUSE  - (-ve)
216 Nalini 30/4802 04.01.12 11.10.12 37 L Spontaneous   - Vaginal  -  - 9 9 2.6 NO  -  -  - (-ve)
217 Nandhini 20/4945 29.03.12 06.12.12 37 M Spontaneous   - Vaginal  -  - 8 9 2.7 NO  -  -  - (-ve)
218 Amala 18/4949 06.01.12 13.10.12 38 L Spontaneous   - Vaginal  - YES 8 8 2.8 NO  -  -  - (-ve)
219 Bhuvaneshwai 25/4935 12.11.11 19.08.12 37 L Induction   - Vaginal  -  - 8 8 2.6 NO  -  -  - (-ve)
220 Shuba 25/4917 09.02.11 16.11.12 37 L Spontaneous   - Vaginal  -  - 9 9 2.5 NO  -  -  - (-ve)
221 Jothi 29/4968 02.01.12 09.10.12 38 M Induction   - Vaginal  -  - 9 9 2.9 NO  -  -  - (-ve)
222 Sheeba 25/4917 20.01.12 27.10.12 38 M Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -  - (-ve)
223 Saraswathy 29/4915 06.02.11 13.11.12 38 M Spontaneous yes INSTURMENTAL  -  - 8 8 2.7 NO  -  -  - (-ve)
224 Gomathi 19/4955 11.01.12 18.10.12 37 M Spontaneous   - Vaginal  -  - 9 9 2.6 NO  -  -  - (-ve)
225 Uma 19/4944 06.09.11 13.08.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.5 NO  -  -  - (-ve)
226 Naseema 19/4591 19.01.12 26.10.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.7 NO  -  -  - (-ve)
227 Asthar 24/4983 21.11.11 28.08.12 38 L Spontaneous   - Vaginal  - YES 9 8 2.8 NO  -  -  - (-ve)
228 Sugapriya 20/4990 03.12.11 10.09.12 35 L Spontaneous   - Vaginal Yes YES 4 4 2.0 YES LBW LBW  -  - POSITIVE
229 Sathiya 20/4970 27.03.12 04.12.12 39 L LSCS   - LSCS  -  - 8 8 3.0 NO  -  -  - (-ve)
230 Vanitha 24/4995 22.11.11 29.08.12 39 M Induction yes Instrumental  -  - 8 8 3.0 NO  -  -  - (-ve)
231 Pushpa 20/4918 13.02.11 20.11.12 37 M Spontaneous   - Vaginal  -  - 9 9 2.5 NO  -  -  - (-ve)
232 Neelam 21/4904 08.10.11 15.07.12 38 L Spontaneous   - LSCS  -  - 8 8 2.8 NO  -  -  - (-ve)
233 Kalaivani 19/5033 04.12.11 11.09.12 37 L Spontaneous   - Vaginal  -  - 8 8 2.6 NO  -  -  - (-ve)
234 Kaveri 21/4826 03.01.12 10.10.12 38 L Spontaneous   - LSCS  -  - 4 7 2.8 NO  -  -  - (-ve)
235 Sujatha 23/5020 17.11.11 24.08.12 37 M Induction   - Vaginal  -  - 8 8 2.5 NO  -  -  - (-ve)
236 Rekha 18/5014 24.03.12 01.12.12 38 M Spontaneous   - Vaginal  -  - 8 9 2.8
YES? 
ANONALY ANONALY
YES? 
ANONALY  - (-ve)
237 Thulukanam 24/4261 02.12.11 09.09.12 37 M Spontaneous   - Vaginal  -  - 9 9 2.7 NO  -  -  - (-ve)
238 Sumangali 19/4097 18.02.11 25.11.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.6 NO  -  -  - (-ve)
239 Saginbanu 24/5062 07.01.12 14.10.12 38 L Spontaneous   - Vaginal  -  - 8 9 2.8 NO  -  -  - (-ve)
240 Shanthi 22/5053 21.02.11 28.11.12 37 M Spontaneous   - Vaginal  -  - 8 8 2.5 NO  -  -  - (-ve)
241 Nadhiya 24/5058 01.03.12 08.12.12 39 L Spontaneous   - Vaginal  -  - 8 8 3.0 NO  -  -  - (-ve)
242 Anitha 23/4128 13.09.11 20.08.12 38 L Spontaneous   - Vaginal  -  - 8 8 2.8 NO  -  -  - (-ve)
243 Saranya 18/5003 30.03.12 07.12.12 37 L Spontaneous   - Vaginal  -  - 9 9 2.7 NO  -  -  - (-ve)
244 Nagavalli 25/4898 04.09.11 11.08.12 37 L Induction   - LSCS  -  - 8 8 2.6 NO  -  -  - (-ve)
245 Parveen 25/5071 11.12.11 18.09.12 38 L Spontaneous   - Vaginal  - YES 9 9 2.8 NO  -  -  - (-ve)
246 Malar 21/5069 23.12.11 30.09.12 38 L Spontaneous   - LSCS  -  - 9 9 2.8 NO  -  -  - (-ve)
247 Sunitha 27/5021 28.03.12 05.12.12 37 M Induction   - Vaginal  -  - 8 8 2.7 NO  -  -  - (-ve)
248 Yasodha 30/5070 08.11.11 15.08.12 37 L Spontaneous   - Instrumental  -  - 4 4 2.4 NO  -  -  - (-ve)
249 Alamelu 20/4987 06.12.11 13.09.12 38 L Induction   - Vaginal  -  - 8 9 2.8 NO  -  -  - (-ve)
250 Suganya 19/5049 26.03.12 03.12.12 39 M Spontaneous yes LSCS  -  - 8 9 3.0 NO  -  -  - (-ve)
